Alignment Healthcare Inc
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
ALHC$7.27-1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(amounts in thousands, except share and per share amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues: | ||
| Earned premiums | $918,043 | $621,556 |
| Other | 8,889 | 7,045 |
| Total revenues | 926,932 | 628,601 |
| Expenses: | ||
| Medical expenses | 820,900 | 573,218 |
| Selling, general, and administrative expenses | 103,831 | 90,512 |
| Depreciation and amortization | 7,594 | 5,977 |
| Total expenses | 932,325 | 669,707 |
| Loss from operations | (5,393) | (41,106) |
| Other expenses: | ||
| Interest expense | 3,950 | 5,427 |
| Other (income) expenses, net | (10) | 42 |
| Total other expenses | 3,940 | 5,469 |
| Loss before income taxes | (9,333) | (46,575) |
| Provision for income taxes | 21 | — |
| Net loss | $(9,354) | $(46,575) |
| Less: Net loss attributable to noncontrolling interest | 240 | 54 |
| Net loss attributable to Alignment Healthcare, Inc. | $(9,114) | $(46,521) |
| Total weighted-average common shares outstanding - basic and diluted | 193,606,438 | 189,005,394 |
| Net loss per share - basic and diluted | $(0.05) | $(0.25) |
Condensed Consolidated Statements of Stockholders' Equity
(amounts in thousands, except par value and share amounts)
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling Interest | Total | |
| Balance at December 31, 2024 | 191,778,639 | $192 | $1,107,952 | $(1,008,293) | $1,104 | $100,955 |
| Net loss | — | — | — | (9,114) | (240) | (9,354) |
| Issuance of common stock upon vesting of restricted stock units | 5,864,819 | — | — | — | — | — |
| Forfeitures | (277) | — | — | — | — | — |
| Equity-based compensation | — | 6 | 17,181 | — | — | 17,187 |
| Stock options exercised | 24,472 | — | 207 | — | — | 207 |
| Balance at March 31, 2025 | 197,667,653 | $198 | $1,125,340 | $(1,017,407) | $864 | $108,995 |
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling interest | Total | |
| Balance at December 31, 2023 | 188,951,643 | $189 | $1,037,015 | $(880,258) | $1,125 | $158,071 |
| Net loss | — | — | — | (46,521) | (54) | (46,575) |
| Issuance of common stock upon vesting of restricted stock units | 2,277,545 | 2 | — | — | — | 2 |
| Forfeitures | (2,799) | — | — | — | — | — |
| Shares withheld related to net restricted stock settlement | (69,820) | — | (350) | — | — | (350) |
| Equity-based compensation | — | — | 20,854 | — | — | 20,854 |
| Noncontrolling interest attributable to subsidiary | — | — | — | — | 15 | 15 |
| Balance at March 31, 2024 | 191,156,569 | $191 | $1,057,519 | $(926,779) | $1,086 | $132,017 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.